Research Article

Effect of Genetic and Laboratory Findings on Clinical Course of Antisynthetase Syndrome in a Hungarian Cohort

Table 3

Detailed comparison according to the stable dose of methylprednisolone.

Minimal stable steroid dose: (n=47)5.57mg±8.436
<8mg≥8mgp

Number of patients:3215-
Male/Female:6/261/140.404
Mean age at disease onset ± SD (youngest-oldest):43.91±13.18(18-70)41.47±14.29(19-67)-

Clinical symptoms and laboratory parameters:

myositis:32100%15100%1
LDH at diagnosis(U/l)±SD:1035.26±707.38775.93±463.930.224
CK at diagnosis(U/l)±SD:3447.64±3176.222531.86±2982.120.374
ILD/alveolitis:2475%1173%1
arthritis:2991%1280%0.367
CRP at diagnosis(mg/l)±SD: 17.84±18.3236.34±25.390.014
ESR at diagnosis(mm/h)±SD:19.81±10.433.87±22.110.032
Raynaud-phenomenon:2166%1067%0.944
dysphagia:26%427%0.072
fever:1134%1067%0.038
Skin lesion:1547%1173%0.089

SD: standard deviation; LDH: lactate dehydrogenase; CK: creatine kinase; ILD: interstitial lung disease; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate.